Our data imply that although heterozygous loss of STK11 with reduction in LKB1 expression may act to predispose to ovarian cancer initiation, maintenance of functional LKB1 signalling is likely essential during metastatic progression to promote cell survival in spheroids and fuel recurrence of chemo-resistant ovarian cancer (Figure 6). Here, STK11 is linked to ovarian cancer.